Version 5.4
Bos taurus Protein: BT.39483
Summary
InnateDB Protein IDBP-681288.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.39483
Protein Name Uncharacterized protein
Synonyms GCFC;
Species Bos taurus
Ensembl Protein ENSBTAP00000003986
InnateDB Gene IDBG-629867 (BT.39483)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0005515 protein binding
GO:0008134 transcription factor binding
Biological Process
GO:0006355 regulation of transcription, DNA-templated
GO:0014842 regulation of satellite cell proliferation
GO:0031062 positive regulation of histone methylation
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:2000288 positive regulation of myoblast proliferation
Cellular Component
GO:0005634 nucleus
GO:0005829 cytosol
Protein Structure and Domains
PDB ID
InterPro IPR022783 GC-rich sequence DNA-binding factor domain
PFAM PF07842
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q0VC46
UniProt Splice Variant
Entrez Gene 514918
UniGene Bt.39483
RefSeq NP_001069157
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC120358 DAAA02000041
GenPept AAI20359

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca